Evidence map›Paper›PMID 42631152›Full record

ArticleACS measurement science au2026

Reversible Microfluidic Platform for Spheroid Culturing, Downstream Characterization, and Dynamic Anticancer Susceptibility Testing.

Iris Renata Sousa Ribeiro, Pedro Henrique Nunes da Silva, Bruna Gabrielle Olsen, Katarina da Silva Vilarins, Eloisa Maria Amador Souza, Isabela Aparecida de Araujo Andreotti, Leandro Ramos Souza Barbosa, Emanuel Carrilho, Angelo Luiz Gobbi, Diego Stefani Teodoro Martinez and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS measurement science au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Iris Renata Sousa RibeiroLaboratório Nacional de Nanotecnologia, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, São Paulo 13083-970, Brazil.ORCID https://orcid.org/0000-0003-0929-5231
Pedro Henrique Nunes da SilvaLaboratório Nacional de Nanotecnologia, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, São Paulo 13083-970, Brazil.ORCID https://orcid.org/0009-0000-6644-1755
Bruna Gabrielle OlsenLaboratório Nacional de Nanotecnologia, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, São Paulo 13083-970, Brazil.ORCID https://orcid.org/0000-0002-5417-6138
Katarina da Silva VilarinsILUM - Escola de Ciências, Campinas, São Paulo 13087-548, Brazil.
Eloisa Maria Amador SouzaILUM - Escola de Ciências, Campinas, São Paulo 13087-548, Brazil.
Isabela Aparecida de Araujo AndreottiLaboratório Nacional de Nanotecnologia, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, São Paulo 13083-970, Brazil.
Leandro Ramos Souza BarbosaInstituto de Física, Universidade de São Paulo, São Paulo 05508-090, Brazil.ORCID https://orcid.org/0000-0001-5997-2160
Emanuel CarrilhoUniversidade de São Paulo, Instituto de Química de São Carlos, São Carlos 13566-590, Brazil.ORCID https://orcid.org/0000-0001-7351-8220
Angelo Luiz GobbiLaboratório Nacional de Nanotecnologia, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, São Paulo 13083-970, Brazil.
Diego Stefani Teodoro MartinezLaboratório Nacional de Nanotecnologia, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, São Paulo 13083-970, Brazil.ORCID https://orcid.org/0000-0002-0086-3055
Renato Sousa LimaLaboratório Nacional de Nanotecnologia, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, São Paulo 13083-970, Brazil.ORCID https://orcid.org/0000-0001-8450-1475

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the potentialities of three-dimensional (3D) spheroids to improve the predictive capability of preclinical

Indexed as

3D cell spheroidsDrug susceptibility testingDynamic perfusion cultureMicrofluidic platformReversible PDMS bonding

Identifiers

PMID42631152
PMCPMC13495713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.